Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

about

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

Item

http://www.wikidata.org/entity/Q52684055

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

@en

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

@nl

type

Item

label

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

@en

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

@nl

prefLabel

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

@en

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

@nl

P1476

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

@en

P2093

Chenxu Liu

http://www.w3.org/2001/XMLSchema#string

Chun Chen

http://www.w3.org/2001/XMLSchema#string

Dongdong Wang

http://www.w3.org/2001/XMLSchema#string

Guanying Zhang

http://www.w3.org/2001/XMLSchema#string

Qunli Wei

http://www.w3.org/2001/XMLSchema#string

Tong Wei

http://www.w3.org/2001/XMLSchema#string

Xiao Chen

http://www.w3.org/2001/XMLSchema#string

Yinhan Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetic nephropathy and extracellular matrix

Safety and efficacy of sitagliptin-metformin in fixed combination for the treatment of type 2 diabetes mellitus

Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms

C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway

Global estimates of the prevalence of diabetes for 2010 and 2030

The pathobiology of diabetic complications: a unifying mechanism

US Renal Data System 2010 Annual Data Report.

L-Endoglin overexpression increases renal fibrosis after unilateral ureteral obstruction.

Diabetic nephropathy: mechanisms of renal disease progression.

Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats

P304

2784-2792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJMM.2018.3504

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29484381

http://www.w3.org/2001/XMLSchema#string

P932

5846674

http://www.w3.org/2001/XMLSchema#string